2 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow Lansoprazole 15 mg: new trials by email Literature Review of Lansoprazole 15 mg trials Research Report on Lansoprazole 15 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer DWP14012 20mg, Lansoprazole 15 mg, DWP14012 20mg placebo - Peptic Ulcer | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 423 | 2021-05-21 | 2024-07-08 |
| Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs Lansoprazole 15 mg, Tegoprazan 25 mg - Preventive Peptic Ulcer | Phase 3 | Completed | HK inno.N Corporation | 392 | 2021-05-07 | 2026-09-14 |
| Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis DWP14012 20 mg, DWP14012 20 mg placebo, Lansoprazole 15 mg - Healed Erosive Esophagitis | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 406 | 2020-07-02 | 2020-09-03 |
Peptic Ulcer (1)
Daewoong Pharmaceutical Co. LTD. (2) · HK inno.N Corporation (1)
South Korea (3)
Jea Jun Kim (1)